Klappentext

Electrocardiographic Left Ventricular Hypertrophy: Looking Beyond Left Ventricular Mass offers a fresh perspective on the use of electrocardiograms (ECGs) for treating left ventricular hypertrophy (LVH). The book bridges the gap between recent research findings and clinical practice, aiming to advance the technology into the future. It emphasizes the unique insights that ECGs provide regarding the cardiac electric field in LVH patients, pushing for a shift in the traditional diagnostic approach of ECG for LVH. The book addresses the need to reconsider classical diagnostic paradigms and focuses on false-negative ECG results that actually contain valuable, often overlooked information.

These results can be crucial for diagnostics, selecting targeted therapy, and assessing cardiovascular risk. By maximizing the potential of ECG technology, the book aims to enhance patient outcomes and bring innovation to cardiac healthcare.

Inhalt

1. The variety of QRS patterns in LVH and their electro-physiological interpretation
   
   2. Effect of volumetric and conductivity changes in the left ventricle on QRS complex morphology in simulations
   3. Electrocardiographic criteria for left ventricular hypertrophy diagnosis
   4. Echocardiographic diagnosis of left ventricular hypertrophy and its compatibility with ECG criteria: the "false negative" ECG
   5. ST segment strain pattern in LVH
   6. QT interval dynamics in LVH
   7. Manifestation of surface ECG conduction abnormalities by hypertrophy
   8. Clinical conditions associated with LVH
   9. Arrhythmia and associated ECG characteristics in left ventricular hypertrophy
   10. Electrocardiographic and echocardiographic differences in the athlete's heart: a special category
   11. The discrepancy between wall thickness and myocardial mass and ECG appearances in some cardiomyopathies
   12. Electrocardiographic left ventricular hypertrophy and stroke
   13. Evolving LVH: heart failure
   14. How far should BP be lowered in middle-aged and elderly patients with hypertension and ECG-LVH?
   15. Surgical Approaches in Hypertrophic Cardiomyopathy Treatment
   16. Genetic Factors Underlies Cardiac Hypertrophy and Influences Its Clinical Phenotype
   17. Addition of serum biomarkers carboxy-terminal propeptide of procollagen type I (PICP) and NT-proBNP levels to electrocardiography criteria for detection of left ventricular hypertrophy: The Predimed Plus trial
   18. Epidemiology, prognosis and AI-ECG
   19. Artificial intelligence for detecting left ventricular hypertrophy using electrocardiography